Search

Joyce Stellabott Phones & Addresses

  • 425 Telegraph Rd, Perkasie, PA 18944 (215) 453-0648
  • Chalfont, PA

Resumes

Resumes

Joyce Stellabott Photo 1

Associate Principal Scientist

View page
Location:
Perkasie, PA
Industry:
Pharmaceuticals
Work:
Merck
Associate Principal Scientist

Cutech Feb 1999 - Jul 1999
Lab Technician

Rohm and Haas 1996 - 1999
Lab Technician
Education:
Delaware Valley University
Bachelors, Bachelor of Science, Chemistry
Skills:
Hplc
Dissolution
Physical Characterization of Api
Solubility
Chemical and Physical Stability
Preformulation
On Site Formulations
Animal Formulations
Project Teams
Microsoft Excel
Chromotography Software
Electronic Lab Notebooks
Differential Scanning Calorimetry
Thermal Gravimetric Analysis
Moisturesorption Isotherm
Xrpd
Optical Microscopy
Joyce Stellabott Photo 2

Associate Principal Scientist

View page
Location:
Perkasie, PA
Industry:
Pharmaceuticals
Work:
Merck
Associate Principal Scientist
Education:
Delaware Valley University
Skills:
Physio Chemical Characterization Drug Substance
Solubility
On Site Formulation
High Performance Liquid Chromatography
Preformulation

Publications

Us Patents

Polymorphs Of An Androgen Receptor Modulator

View page
US Patent:
7365202, Apr 29, 2008
Filed:
Dec 4, 2006
Appl. No.:
11/633152
Inventors:
Lushi Tan - Edison NJ, US
Robert S. Meissner - Schwenksville PA, US
Wenjie Li - Hopewell Junction NY, US
James J. Perkins - Churchville PA, US
Aaron S. Cote - West Windsor NJ, US
Joyce Stellabott - Perkasie PA, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 221/18
US Classification:
546 77
Abstract:
Compounds of structural formula I are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can be ameliorated by androgen administration, including osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, bone fracture, bone damage following bone reconstructive surgery, sarcopenia, frailty, aging skin, male hypogonadism, postmenopausal symptoms in women, atherosclerosis, hypercholesterolemia, hyperlipidemia, obesity, aplastic anemia and other hematopoietic disorders, inflammatory arthritis and joint repair, HIV-wasting, prostate cancer, benign prostatic hyperplasia (BPH), abdominal adiposity, metabolic syndrome, type II diabetes, cancer cachexia, Alzheimer's disease, muscular dystrophies, cognitive decline, sexual dysfunction, sleep apnea, depression, premature ovarian failure, and autoimmune disease, alone or in combination with other active agents.

Formulations Of Antiviral Compounds

View page
US Patent:
20210361663, Nov 25, 2021
Filed:
Oct 21, 2019
Appl. No.:
17/286620
Inventors:
Sutthilug SOTTHIVIRAT - West Poin PA, US
Joyce STELLABOTT - West Point PA, US
Walter R. WASYLASCHUK - West Point PA, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/5365
A61K 9/20
Abstract:
The present disclosure is directed to pharmaceutical formulations comprising an amorphous inhibitor of hepatitis C vims NS5A. These pharmaceutical formulations may be prepared by roller-compaction or wet-granulation methods. The present disclosure is also directed to oral dosage forms, such as tablets, comprising such pharmaceutical formulations.

Pseudopolymorphs Of An Hcv Ns5A Inhibitor And Uses Thereof

View page
US Patent:
20160311834, Oct 27, 2016
Filed:
Oct 24, 2014
Appl. No.:
15/032663
Inventors:
Michael McNEVIN - Basking Ridge NJ, US
Yong LIU - Princeton NJ, US
Ian MANGION - Cranford NJ, US
Alfred LEE - Robbinsville NJ, US
Joyce STELLABOTT - Perkasie PA, US
Benjamin D. SHERRY - New York NY, US
Gary MARTIN - Warren Township NJ, US
Kung-I FENG - Basking Ridge NJ, US
Scott SHULTZ - Maplewood NJ, US
Ryan COHEN - Piscataway NJ, US
Yanfeng ZHANG - Suzhou, CN
International Classification:
C07D 498/04
A61K 45/06
A61K 31/5383
Abstract:
The present invention relates to novel Pseudopolymorphs of Compound A, compositions comprising at least one Pseudopolymorph of Compound A, and methods of using the Pseudopolymorphs of Compound A for preparing compositions useful for treating or preventing HCV infection in a patient, wherein Compound A has the structure.
Joyce M Stellabott from Perkasie, PA, age ~58 Get Report